Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02736266
Title Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Indications

transitional cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.